Standout Papers

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma 2020 2026 2022 2024899
  1. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma (2020)
    David A. Reardon, Alba A. Brandes et al. JAMA Oncology
  2. Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies (2022)
    Charles A. Powell, Shanu Modi et al. ESMO Open

Citation Impact

1 by Nobel laureates 60 standout
Sub-graph 1 of 22

Citing Papers

Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
2024 Standout
4 intermediate papers

Works of Corina Taitt being referenced

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
2020 Standout

Author Peers

Author Oncology PRM Genetics Immunology Last Decade Papers Cites
Corina Taitt 629 311 593 378 14 1.1k
Venu Vadlamudi 3 88 5 4 28 195
Jennifer Savoie 130 53 6 5 16 328
David C. Boris 3 10 1 8 716
Francesca Rosone 11 20 342
Marg Cosgriff 1 23 161

All Works

Loading papers...

Rankless by CCL
2026